Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (4558)	6/25/1998 11:07:00 AM
From: billkirn	Read Replies (2) of 6136

Richard, Peter, and all: Here is an interesting commentary from an oncologist why EntreMeds angiogenesis inhibitors are something very special and unprecedented in cancer research. messages.yahoo.com@m2.yahoo.com From your experiences, does this seem real, and if so what do you think the probability is that EntreMed will get this combination into the market in the next 2 years? This may be Agouron's competition in the near future. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next